Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai 600077, India.
IRCCS Fondazione Don Carlo Gnocchi, Milan 20148, Italy.
World J Gastroenterol. 2023 Jan 21;29(3):503-507. doi: 10.3748/wjg.v29.i3.503.
Although different studies have associated coronavirus disease 2019 (COVID-19) with the occurrence of liver injury, the hepatic injury route during the COVID-19 course is not yet fully understood. In order to better understand the mechanisms of the disease, the human gut microbiota has been the subject of extensive discussion in the context of COVID-19 pathophysiology. However, many questions remain, including the risks of liver injury due to COVID-19 specific populations. Further research in this field could allow the discovery of new personalized treatment strategies aimed at improving the microbiota composition, thereby reducing COVID-19 severity and its complications in different populations. In this article, we discussed basic mechanisms of severe acute respiratory syndrome coronavirus 2 infection and recent evidence on the relationship between COVID-19, the gut microbiome and liver injury as well as proposed recommendations for further research.
虽然不同的研究将 2019 年冠状病毒病(COVID-19)与肝损伤的发生联系起来,但 COVID-19 病程中的肝损伤途径尚不完全清楚。为了更好地了解疾病的机制,人类肠道微生物群在 COVID-19 病理生理学背景下受到了广泛的讨论。然而,仍有许多问题有待解决,包括 COVID-19 特定人群因肝损伤的风险。该领域的进一步研究可能会发现新的个性化治疗策略,旨在改善微生物群组成,从而降低不同人群 COVID-19 的严重程度及其并发症。在本文中,我们讨论了严重急性呼吸综合征冠状病毒 2 感染的基本机制以及 COVID-19、肠道微生物群和肝损伤之间关系的最新证据,并提出了进一步研究的建议。